Progress in Tripterygium wilfordiiand its bioactive components in the field of pharmacodynamics and pharmacology

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 4, 2010, Pages 515-520

  Shui, Guangxing ^a   Wan, Yigang ^b   Jiang, Chunming ^b   Zhang, Huilan ^a   Chen, Ping ^a   Wang, Chaojun ^a   Yao, Jian ^c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Clinical effect; Mechanism of pharmacology; Multi glycoside of Tripterygium wilfordii(GTW); Triptolide (T4)

Indexed keywords

TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE;

ARTHRALGIA; ARTICLE; CHINESE MEDICINE; DRUG EFFECT; DRUG INDICATION; DRUG RESEARCH; FERTILITY; GRAFT REJECTION; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PHARMACODYNAMICS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; PSORIASIS; RHEUMATOID ARTHRITIS; SKIN DEFECT; SYMPTOM; TRADITIONAL MEDICINE; TRIPTERYGIUM; TUMOR GROWTH;

ANIMALS; BIOMEDICAL RESEARCH; DRUG THERAPY; DRUGS, CHINESE HERBAL; HUMANS; PHARMACOLOGY; TRIPTERYGIUM;

EID: 77952234474     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20100425     Document Type: Article

References (45)

1. Ma J S, Brach A R, Liu Q R. A revision of the genus Tripterygium (Celastraceae) [J]. Edinburgh J Bot, 1999, 56: 33.
2. Ma J, Dey M, Yang H, et al. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii [J]. Phytochemisty, 2007, 68: 1172. (Pubitemid 46528460)
3. Li X Y. Anti-inflammatory and immunosuppressive components of Tripterygium wilfordii Hook. f. [J]. Int J Immunother, 1993, 9: 181.
4. Tao X, Lipsky P E. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook. f [J]. Rheum Dis Clin N Amer, 2000, 26: 29. (Pubitemid 30091720)
5. Brinker A M, Ma J, Lipsky P E, et al. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) [J]. Phytochemisty, 2007, 68(6): 1819.
6. Cibere J, Deng Z, Lin Y, et al. A randomized double blind placebo controlled trail of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis [J]. J Rheumatol, 2003, 30: 465. (Pubitemid 36301935)
7. Tao X, Younger J, Fan F Z, et al. Benefit of an extract of Tripterygium wilfordii Hook. f. in patients with rheumatoid arthritis [J]. Arthritis Rheum, 2002, 46: 1735.
8. Ji S M, Wang Q W, Chen J S, et al. Clinical trial of Tripterygium wilfordii Hook. f. in human kidney transplantation in China [J]. Transplant Proc, 2006, 38: 1274.
9. Wu S X, Guo N R. Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris [J]. Chin J Integr Med, 2005, 11: 147.
10. Mclellan A D, Kampgen E. Functions of myeloid and lymphoid dendritic cells [J]. Immunol Lett, 2000, 72: 101. (Pubitemid 30332305)
11. Dirsch V M, Kiemer A K, Wagner H, et al. The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages [J]. Eur J Pharmacol, 1997, 336: 211. (Pubitemid 27464867)
12. Tao X, Schulze-Koops H, Ma L, et al. Effects of Tripterygium wilfordii Hook. f. extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production [J]. Arthritis Rheum, 1998, 41: 130.
13. Hwang B Y, Lee J H, Koo T H, et al. Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-κB activation in LPS-stimulated macrophage RAW264.7 cells [J]. Planta Med, 2001, 67: 406.
14. Wiggins R C. The spectrum of podocytopathies: a unifying view of glomerular diseases [J]. Kidney Int, 2007, 71: 1205.
15. Zheng C X, Chen Z H, Zeng C H, et al. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro [J]. Kidney Int, 2008, 74: 596.
16. Chan E W, Cheng S C, Sin F W, et al. Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines [J]. Toxicol Lett, 2001, 122: 81.
17. Li H, Liu Z H, Dai C S, et al. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells [J]. Acta Pharmacol Sin, 2002, 23: 775.
18. Xu G, Tu W, Jiang D, et al. Tripterygium wilfordii Hook. f. treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis [J]. Nephron Clin Pract, 2009, 111: c223.
19. Nakajo A, Khoshnoodi J, Takenaka H, et al. Mizoribine corrects nephrin biogenesis by restoring intracellular energy balance [J]. J Am Soc Nephrol, 2007, 18: 2554. (Pubitemid 47378872)